FI954580A0 - HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon - Google Patents

HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon

Info

Publication number
FI954580A0
FI954580A0 FI954580A FI954580A FI954580A0 FI 954580 A0 FI954580 A0 FI 954580A0 FI 954580 A FI954580 A FI 954580A FI 954580 A FI954580 A FI 954580A FI 954580 A0 FI954580 A0 FI 954580A0
Authority
FI
Finland
Prior art keywords
treatment
aids
protease inhibitors
hiv protease
compounds
Prior art date
Application number
FI954580A
Other languages
English (en)
Swedish (sv)
Other versions
FI954580A (fi
Inventor
Joseph P Vacca
James P Guare
Bruce D Dorsey
M Katharine Holloway
Randall W Hungate
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI954580A publication Critical patent/FI954580A/fi
Publication of FI954580A0 publication Critical patent/FI954580A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
FI954580A 1993-03-31 1995-09-27 HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon FI954580A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31
PCT/US1994/003209 WO1994022480A1 (en) 1993-03-31 1994-03-24 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids

Publications (2)

Publication Number Publication Date
FI954580A FI954580A (fi) 1995-09-27
FI954580A0 true FI954580A0 (fi) 1995-09-27

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954580A FI954580A0 (fi) 1993-03-31 1995-09-27 HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon

Country Status (35)

Country Link
EP (1) EP0617968B1 (fi)
JP (1) JPH08508496A (fi)
KR (1) KR100311551B1 (fi)
CN (1) CN1090186C (fi)
AT (1) ATE230610T1 (fi)
AU (1) AU685772B2 (fi)
BG (1) BG62083B1 (fi)
BR (1) BR9406503A (fi)
CA (1) CA2120192A1 (fi)
CY (1) CY2326B1 (fi)
CZ (1) CZ286412B6 (fi)
DE (1) DE69431972T2 (fi)
DK (1) DK0617968T3 (fi)
DZ (1) DZ1766A1 (fi)
ES (1) ES2188604T3 (fi)
FI (1) FI954580A0 (fi)
HK (1) HK1009248A1 (fi)
HR (1) HRP940209B1 (fi)
HU (1) HUT74006A (fi)
IL (1) IL109166A (fi)
LV (1) LV13141B (fi)
NO (1) NO953876L (fi)
NZ (1) NZ265164A (fi)
PL (1) PL310895A1 (fi)
PT (1) PT617968E (fi)
RO (1) RO118000B1 (fi)
RU (1) RU2139052C1 (fi)
SA (1) SA94140745B1 (fi)
SG (1) SG64366A1 (fi)
SI (1) SI9420017B (fi)
SK (1) SK279471B6 (fi)
TW (1) TW307684B (fi)
WO (1) WO1994022480A1 (fi)
YU (1) YU49275B (fi)
ZA (1) ZA942255B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288312B6 (en) * 1993-12-15 2001-05-16 Merck & Co Inc HIV-protease inhibitors and pharmaceutical preparations in which they are comprised
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
JPH10507917A (ja) * 1994-10-25 1998-08-04 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤の微生物合成
US6689761B1 (en) 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
WO2000002862A1 (en) 1998-07-08 2000-01-20 G.D. Searle & Co. Retroviral protease inhibitors
AU6508899A (en) 1998-10-13 2000-05-01 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US8013006B2 (en) 2004-07-14 2011-09-06 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007000762A (es) 2004-07-22 2007-04-02 Ptc Therapeutics Inc Tienopiridinas para tratamientode hepatitis c.
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508146A (ja) * 1991-06-04 1994-09-14 スミスクライン・ビーチャム・コーポレイション 炭素環および複素環式ｈｉｖプロテアーゼ抑制剤

Also Published As

Publication number Publication date
JPH08508496A (ja) 1996-09-10
RU2139052C1 (ru) 1999-10-10
CZ286412B6 (en) 2000-04-12
HU9502860D0 (en) 1995-11-28
SI9420017B (sl) 2003-12-31
KR960701661A (ko) 1996-03-28
FI954580A (fi) 1995-09-27
LV13141B (en) 2004-08-20
DZ1766A1 (fr) 2002-02-17
IL109166A0 (en) 1994-06-24
CN1090186C (zh) 2002-09-04
HRP940209B1 (en) 2004-04-30
RO118000B1 (ro) 2002-12-30
SI9420017A (en) 1996-10-31
BG100016A (en) 1996-04-30
DE69431972D1 (de) 2003-02-13
CN1120316A (zh) 1996-04-10
TW307684B (fi) 1997-06-11
NO953876L (no) 1995-11-30
AU5921394A (en) 1994-10-06
HUT74006A (en) 1996-10-28
ATE230610T1 (de) 2003-01-15
NO953876D0 (no) 1995-09-29
PT617968E (pt) 2003-03-31
YU49275B (sh) 2005-03-15
CZ252895A3 (en) 1996-07-17
EP0617968A1 (en) 1994-10-05
AU685772B2 (en) 1998-01-29
SA94140745B1 (ar) 2006-07-11
HRP940209A2 (en) 1998-02-28
EP0617968B1 (en) 2003-01-08
ZA942255B (en) 1994-11-01
SK122595A3 (en) 1997-03-05
DK0617968T3 (da) 2003-02-24
KR100311551B1 (ko) 2001-12-28
DE69431972T2 (de) 2003-08-28
BR9406503A (pt) 1996-01-02
IL109166A (en) 1999-08-17
SK279471B6 (sk) 1998-11-04
SG64366A1 (en) 1999-04-27
ES2188604T3 (es) 2003-07-01
NZ265164A (en) 1997-09-22
PL310895A1 (en) 1996-01-08
BG62083B1 (bg) 1999-02-26
CA2120192A1 (en) 1994-10-01
WO1994022480A1 (en) 1994-10-13
CY2326B1 (en) 2003-11-14
HK1009248A1 (en) 1999-05-28
YU15994A (sh) 1999-06-15

Similar Documents

Publication Publication Date Title
FI954580A0 (fi) HIV-proteaasin estäjiä farmaseuttisissa yhdistelmissä käytettäväksi AIDSin hoitoon
ATE175412T1 (de) Hiv-protease-inhibitoren
ES2072959T3 (es) Derivados de aminoacido.
DE69531944D1 (de) Neue hiv-protease-inhibitoren
ATE215952T1 (de) Hiv-proteaseinhibitoren